Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COMy 2016 | Improving strategies for executing successful clinical trials in multiple myeloma

Eric Low • 8 Jun 2016
COMy 2016
Multiple Myeloma

Eric Low, Chief Executive of Myeloma UK, explains the evolving strategies for improving the drug development process for therapies for patients with multiple myeloma so that the right therapies are delivered to the right patients. One such strategy is the Myeloma UK’s Clinical Trial Network, which comprises of experts, hospitals and research centres across the UK aimed at accelerating the testing of and access to new myeloma therapies. Recorded at the 2016 World Congress on Controversies in Multiple Myeloma (COMy) in Paris, France.

More from Eric Low

2:50
Why global collaborations are key in multiple myeloma
Eric Low • 28 Apr 2016
2:36
The price of new innovation for the treatment of multiple myeloma
Eric Low • 12 Apr 2016
1:41
Myeloma UK as a driver of collaboration between industry and academia
Eric Low • 7 Oct 2016
3:05
The rationale behind the Myeloma UK Clinical Trial Network
Eric Low • 7 Oct 2016

Related Videos

1:47
Looking forward to the Miami Myeloma MRD Virtual Meeting 2024
Ola Landgren • 13 Apr 2024
2:27
The encouraging results of the LINKER-MM1 trial: safety and efficacy of linvoseltamab in R/R myeloma
Faith Davies • 9 Apr 2024
0:37
Upcoming studies investigating linvoseltamab in myeloma
Faith Davies • 9 Apr 2024
3:23
Molecular characteristics associated with increased risk of disease progression in SMM
Mark Bustoros • 27 Sep 2023
The content of VJHemOnc is intended for healthcare professionals